Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo
Author:
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference34 articles.
1. Clinical applications of angiogenic growth factors and their inhibitors
2. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
3. Vascular-specific growth factors and blood vessel formation
4. VEGF and the quest for tumour angiogenesis factors
5. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression;Cancers;2024-05-08
2. TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth;Antibodies;2024-02-01
3. Antibody Libraries as Platforms to Exploring Target and Receptor Pleiotropy;Israel Journal of Chemistry;2023-05-31
4. Insight on the cellular and molecular basis of blood vessel formation: A specific focus on tumor targets and therapy;MedComm – Oncology;2023-02-08
5. Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions;Antibodies;2022-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3